Dongwon Global Terminal and Young Chemical Sign Investment Agreements

Expansion of Advanced Port Facilities and Medical Supplies Manufacturing Facilities

KRW 300 billion will be invested in expanding automated facilities at Busan New Port and building a new medical supplies manufacturing plant. Dongwon Global Terminal Busan Co., Ltd. and Young Chemical Co., Ltd. have decided to make large-scale investments in the Busan-Jinhae Free Economic Zone, boosting efforts to upgrade port logistics and expand the region's manufacturing base.


The Busan-Jinhae Free Economic Zone Authority, headed by Park Seong-ho, announced that it had signed investment agreements (MOUs) with the two companies, together with Gyeongsangnam-do and Changwon City, at the 2026 Gyeongsangnam-do Metropolitan Area Investment Promotion Briefing held at The Westin Josun Seoul on October 20.


The total investment amounts to KRW 300 billion and is expected to create 148 new jobs. The investments are divided between port logistics and medical supplies manufacturing.

Investment agreements are being signed at an investment promotion briefing hosted by Gyeongsangnam-do.

Investment agreements are being signed at an investment promotion briefing hosted by Gyeongsangnam-do.

View original image

Dongwon Global Terminal will invest KRW 200 billion by 2028 to expand advanced port operating facilities around the western container terminal at Busan New Port in Jinhae-gu, Changwon City. It plans to increase its fleet of automated guided vehicles, cargo-handling equipment, and operating systems to strengthen its smart port capabilities, and hire 88 new employees.


A subsidiary of Dongwon Group, Dongwon Global Terminal opened the country's first fully automated container terminal at the western container terminal of Busan New Port in April 2024.

It automates the process from loading and unloading containers to their transport and storage using automated guided vehicles (AGVs), automated container cranes, and an integrated operating system. It has also introduced eco-friendly electric-powered equipment to improve both port operating efficiency and environmental performance.


Young Chemical, a company specializing in medical supplies, will expand its manufacturing facilities. By 2029, it will invest KRW 100 billion to build new medical supplies and cosmetics manufacturing facilities on a site of approximately 33,000 square meters in Phase 2 of the Ungdong Hinterland Complex in Jinhae-gu, Changwon City. The company plans to increase production capacity, expand its business areas, and create 60 new jobs.


Founded in 1986, Young Chemical is a medical supplies manufacturer based in Gimhae, Gyeongsangnam-do. It develops and manufactures wound care products, including disposable adhesive bandages, medical adhesive tape, and wound dressings, and operates its own PLAID brand. The company has expanded its business in domestic and international markets through research and development and advances in production technology.


The agreement stands out because investments in automated port facilities and medical supplies manufacturing facilities are being made at the same time. The authority expects the investments to strengthen the competitiveness of the port logistics industry, broaden the base for manufacturers to establish operations in the area, diversify the regional industrial structure, and contribute to job creation.


Park Seong-ho said, "This will be an opportunity to enhance Busan New Port's competitiveness as a smart port and expand the manufacturing base of the Busan-Jinhae Free Economic Zone," expressing his commitment to ensuring that the companies' investments proceed without a hitch.



The authority will work with Gyeongsangnam-do and Changwon City to support administrative procedures, including permits and approvals, and address the companies' challenges, helping ensure that the investment plans are implemented smoothly.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing